Related references
Note: Only part of the references are listed.Circadian molecular clocks and cancer
Fergal C. Kelleher et al.
CANCER LETTERS (2014)
Optimized Chemical Probes for REV-ERBα
Ryan P. Trump et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
mTOR inhibits autophagy by controlling ULK1 ubiquitylation, self-association and function through AMBRA1 and TRAF6
Francesca Nazio et al.
NATURE CELL BIOLOGY (2013)
Rev-erb-alpha modulates skeletal muscle oxidative capacity by regulating mitochondrial biogenesis and autophagy
Estelle Woldt et al.
NATURE MEDICINE (2013)
Mammalian TIMELESS Is Involved in Period Determination and DNA Damage-Dependent Phase Advancing of the Circadian Clock
Erik Engelen et al.
PLOS ONE (2013)
Monitoring autophagic flux by an improved tandem fluorescent-tagged LC3 (mTagRFP-mWasabi-LC3) reveals that high-dose rapamycin impairs autophagic flux in cancer cells
Cuihong Zhou et al.
AUTOPHAGY (2012)
Guidelines for the use and interpretation of assays for monitoring autophagy
Daniel J. Klionsky et al.
AUTOPHAGY (2012)
Entrainment of breast (cancer) epithelial cells detects distinct circadian oscillation patterns for clock and hormone receptor genes
Stefano Rossetti et al.
CELL CYCLE (2012)
Fluorine local environment: from screening to drug design
Anna Vulpetti et al.
DRUG DISCOVERY TODAY (2012)
Rev-erbα and Rev-erbβ coordinately protect the circadian clock and normal metabolic function
Anne Bugge et al.
GENES & DEVELOPMENT (2012)
Circadian Rhythm Disruption in Cancer Biology
Christos Savvidis et al.
MOLECULAR MEDICINE (2012)
Regulation of circadian behaviour and metabolism by synthetic REV-ERB agonists
Laura A. Solt et al.
NATURE (2012)
Regulation of circadian behaviour and metabolism by REV-ERB-α and REV-ERB-β
Han Cho et al.
NATURE (2012)
Deconvoluting the context-dependent role for autophagy in cancer
Eileen White
NATURE REVIEWS CANCER (2012)
Identification of SR8278, a Synthetic Antagonist of the Nuclear Heme Receptor REV-ERB
Douglas Kojetin et al.
ACS CHEMICAL BIOLOGY (2011)
Structure-guided design and synthesis of P1′ position 1-phenylcycloalkylamine-derived pentapeptidic BACE1 inhibitors
Harichandra D. Tagad et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2011)
Lucanthone Is a Novel Inhibitor of Autophagy That Induces Cathepsin D-mediated Apoptosis
Jennifer S. Carew et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
The gluttonous side of malignant melanoma: basic and clinical implications of macroautophagy
Agnieszka Checinska et al.
PIGMENT CELL & MELANOMA RESEARCH (2011)
A high content screening assay for identifying lysosomotropic compounds
Sashi Nadanaciva et al.
TOXICOLOGY IN VITRO (2011)
Choosing the right cell line for breast cancer research
Deborah L. Holliday et al.
BREAST CANCER RESEARCH (2011)
An RNA Interference Screen Identifies Metabolic Regulators NR1D1 and PBP as Novel Survival Factors for Breast Cancer Cells with the ERBB2 Signature
Antonis Kourtidis et al.
CANCER RESEARCH (2010)
Synergistic Chemosensitivity of Triple-Negative Breast Cancer Cell Lines to Poly(ADP-Ribose) Polymerase Inhibition, Gemcitabine, and Cisplatin
Kedar Hastak et al.
CANCER RESEARCH (2010)
PER2 Controls Lipid Metabolism by Direct Regulation of PPARγ
Benedetto Grimaldi et al.
CELL METABOLISM (2010)
Regulation of Adipogenesis by Natural and Synthetic REV-ERB Ligands
Naresh Kumar et al.
ENDOCRINOLOGY (2010)
Targeted Activation of Innate Immunity for Therapeutic Induction of Autophagy and Apoptosis in Melanoma Cells
Damia Tormo et al.
CANCER CELL (2009)
Chromatin remodeling, metabolism and circadian clocks: The interplay of CLOCK and SIRT1
Benedetto Grimaldi et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2009)
How nuclear receptors tell time
Michele Teboul et al.
JOURNAL OF APPLIED PHYSIOLOGY (2009)
Rev-erb-α: an integrator of circadian rhythms and metabolism
Helene Duez et al.
JOURNAL OF APPLIED PHYSIOLOGY (2009)
Loss of cryptochrome reduces cancer risk in p53 mutant mice
Nuri Ozturk et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Metabolism and cancer: the circadian clock connection
Saurabh Sahar et al.
NATURE REVIEWS CANCER (2009)
The efficacy and selectivity of tumor cell killing by Akt inhibitors are substantially increased by chloroquine
Changkun Hu et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2008)
Atomic property fields: Generalized 3D pharmacophoric potential for automated ligand superposition, pharmacophore elucidation and 3D QSAR
Maxim Totrov
CHEMICAL BIOLOGY & DRUG DESIGN (2008)
Identification of heme as the ligand for the orphan nuclear receptors REV-ERBα and REV-ERBβ
Srilatha Raghuram et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2007)
Identification and validation of an ERBB2 gene expression signature in breast cancers
F Bertucci et al.
ONCOGENE (2004)
A clockwork web: Circadian timing in brain and periphery, in health and disease
MH Hastings et al.
NATURE REVIEWS NEUROSCIENCE (2003)
The circadian clock: Pacemaker and tumour suppressor
LN Fu et al.
NATURE REVIEWS CANCER (2003)
HER-2/neu gene copy number quantified by real-time PCR:: Comparison of gene amplification, heterozygosity, and immunohistochemical status in breast cancer tissue
M Königshoff et al.
CLINICAL CHEMISTRY (2003)
Fluorine-NMR competition binding experiments for high-throughput screening of large compound mixtures
C Dalvit et al.
COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING (2002)
Resetting of circadian time peripheral tissues by glucocorticoid signaling
A Balsalobre et al.
SCIENCE (2000)
Share Paper
